BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 21063893)

  • 1. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
    Amiot L; Ferrone S; Grosse-Wilde H; Seliger B
    Cell Mol Life Sci; 2011 Feb; 68(3):417-31. PubMed ID: 21063893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathways: human leukocyte antigen G (HLA-G).
    Curigliano G; Criscitiello C; Gelao L; Goldhirsch A
    Clin Cancer Res; 2013 Oct; 19(20):5564-71. PubMed ID: 23897901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of HLA-G in therapy of cancer].
    Zidi I; Bartegi A
    Therapie; 2008; 63(4):327-32. PubMed ID: 18937912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotolerant functions of HLA-G.
    Carosella ED; Dausset J; Rouas-Freiss N
    Cell Mol Life Sci; 1999 Mar; 55(3):327-33. PubMed ID: 10228553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy.
    Yan WH
    Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):76-89. PubMed ID: 21348818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-G expression in malignant melanoma.
    Rebmann V; Wagner S; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
    Yie SM; Hu Z
    Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biological significance of HLA-G expression in ovarian cancer.
    Sheu JJ; Shih IeM
    Semin Cancer Biol; 2007 Dec; 17(6):436-43. PubMed ID: 17681474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-G promotes immune tolerance.
    Rouas-Freiss N; Paul P; Dausset J; Carosella ED
    J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
    Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
    Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.
    Ibrahim EC; Allory Y; Commo F; Gattegno B; Callard P; Paul P
    Am J Pathol; 2003 Feb; 162(2):501-8. PubMed ID: 12547708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble HLA-G, its diagnostic and prognostic value and potential target molecule for future therapy in cancer.
    Kluckova K; Durmanova V; Bucova M
    Bratisl Lek Listy; 2021; 122(9):60-617. PubMed ID: 34463104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of human leukocyte antigen-G expression in the diagnosis of human cancer.
    Shih IeM
    Hum Immunol; 2007 Apr; 68(4):272-6. PubMed ID: 17400063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-classical antigens of HLA-G and HLA-E as diagnostic and prognostic biomarkers and as therapeutic targets in transplantation and tumors.
    Seliger B
    Clin Transpl; 2013; ():465-72. PubMed ID: 25095542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
    Agrawal S; Pandey MK
    J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.
    Ishitani A; Sageshima N; Lee N; Dorofeeva N; Hatake K; Marquardt H; Geraghty DE
    J Immunol; 2003 Aug; 171(3):1376-84. PubMed ID: 12874228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphisms, function and clinical effect of HLA-G].
    Meng H; Hou Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):350-3. PubMed ID: 12170478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.
    Donadi EA; Castelli EC; Arnaiz-Villena A; Roger M; Rey D; Moreau P
    Cell Mol Life Sci; 2011 Feb; 68(3):369-95. PubMed ID: 21107637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-G: immune tolerance in normal and pathological physiology].
    Le Discorde M; Moreau P; Rouas-Freiss N; Carosella E
    Pathol Biol (Paris); 2002 Feb; 50(1):45-51. PubMed ID: 11873630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA-G and local placental immunity].
    Le Bouteiller P
    Gynecol Obstet Fertil; 2003 Sep; 31(9):782-5. PubMed ID: 14499728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.